Smoking among women following heart transplantation: Should we be concerned?

Progress in Cardiovascular Nursing

Volumn 24, Issue 4, 2009, Pages 119-123

  Evangelista, Lorraine ^a   Ter Galstanyan, Alvina ^a   Moser, Debra K ^b   Dracup, Kathleen ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; HEART TRANSPLANTATION; HIGH RISK BEHAVIOR; HUMAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; PASSIVE SMOKING; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRE; RISK; SMOKING; STATISTICS; TIME; UNITED STATES; URINE;

CONFIDENCE INTERVALS; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; QUALITY OF LIFE; QUESTIONNAIRES; RISK-TAKING; SMOKING; SOCIAL PERCEPTION; STATISTICS AS TOPIC; TIME FACTORS; TOBACCO SMOKE POLLUTION; UNITED STATES;

EID: 74349086794     PISSN: 08897204     EISSN: 17517117     Source Type: Journal    
DOI: 10.1111/j.1751-7117.2009.00049.x     Document Type: Article

References (25)

1. Heart Disease and Stroke Statistics-2008 Update 2008, American Heart Association, Dallas, TX, American Heart Association
2. Hosenpud JD, Bennett LE, Kecvk BM. The registry of the international society for heart and lung transplantation: sixteenth official report-1999. J Heart Lung Transplant 1999, 18:611-626.
3. Sanchez-Lazaro IJ, Almenar L, Martinez-Dolz L. Impact of smoking on survival after heart transplantation. Transplant Proc 2007, 39:2377-2378.
4. Takayama H, Nathens AB, Merry H. Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation? Eur J Cardiothorac Surg 2007, 31:457-461.
5. Sanchez Lazaro IJ, Almenar Bonet L, Martinez-Dolz L. Effect of hypertension, diabetes, and smoking on development of renal dysfunction after heart transplantation. Transplant Proc 2008, 40:3049-3050.
6. Nagele H, Kalmar P, Rodiger W. Smoking after heart transplantation: an underestimated hazard? Eur J Cardiothoracic Surg 1997, 12:70-74.
7. Basile A, Bernazzali F, Diciolla F. Risk factors for smoking abuse after heart transplantation. Transplant Proc 2004, 36:641-642.
8. Mehra MR, Uber PA, Prasad A. Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers. Am J Transplant 2005, 5:1137-1140.
9. Costanzo MR, Eisen HJ, Brown RN. Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant 2001, 20:152.
10. Lerman C, Orleans C, Engstom P. Biology markers in smoking cessation treatment. Semin Oncol 1999, 20:367.
11. DeSalvo K, Fisher W, Tran K. Assessing measurement properties of two single-item general health measures. Qual Life Res 2006, 15:191-201.
12. SPSS User's Guide Version 13.0 2006, SPSS Inc., 13th ed, Chicago, IL, SPSS Inc.
13. Bolton M, Wilson B. The influence of race on heart failure in African-American women. Medsurg Nursing 2005, 14:8-15.
14. Behera S, Winkleby M, Collins R. Low awareness of cardiovascular disease risk among low-income African-American women. Am J Health Promot 2000, 14:301-305.
15. Yancy CW, Abraham WT, Albert NM. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Col Cardiol 2008, 51:1675-1684.
16. Correa-de-Araujo R, Stevens B, Moy E. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Women's Health Issues 2006, 16:44-55.
17. Botha P, Peaston R, White K. Smoking after cardiac transplantation. Am J Transplant 2008, 8:866-871.
18. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 2008, 6:883-895.
19. Teo KK, Ounpuu S, Hawken S. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006, 368:647-658.
20. Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 2001, 158:257-267.
21. Howard G, Wagenknecht LE, Cai J. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 1998, 29:913-917.
22. Stork S, Behr TM, Birk M. Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary? J Heart Lung Transplant 2006, 25:1103-1108.
23. Lazaro IJS, Bonet LA, Lopez JM. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation. Transplant Proc 2008, 40:3056-3057.
24. Winter L, Lawton MP, Langston CA. Symptoms, affects, and self-rated health: evidence for a subjective trajectory of health. J Aging Health 2007, 19:453-469.
25. Wolinsky FD, Miller TR, Malmstrom TK. Self-rated health: changes, trajectories, and their antecedents among African Americans. J Aging Health 2008, 20:143-158.